切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2016, Vol. 05 ›› Issue (02) : 56 -60. doi: 10.3877/cma.j.issn.2095-3216.2016.02.003

所属专题: 文献

专家论坛

膀胱输尿管反流的精准诊治进展
徐虹1,(), 张欣1, 陈宏2   
  1. 1. 201102 上海,复旦大学附属儿科医院肾内科
    2. 复旦大学附属儿科医院泌尿外科
  • 收稿日期:2016-03-04 出版日期:2016-04-28
  • 通信作者: 徐虹
  • 基金资助:
    国家自然科学基金青年项目(81400684,81200487)

Progress of precise diagnosis and treatment for vesicoureteral reflux

Hong Xu1,(), Xin Zhang1, Hong Chen2   

  1. 1. Department of Nephrology, Pediatric Hospital Affiliated to Fudan University, Shanghai 201102, China
    2. Department of Urology, Pediatric Hospital Affiliated to Fudan University, Shanghai 201102, China
  • Received:2016-03-04 Published:2016-04-28
  • Corresponding author: Hong Xu
  • About author:
    Corresponding author: Xu Hong, Email:
引用本文:

徐虹, 张欣, 陈宏. 膀胱输尿管反流的精准诊治进展[J/OL]. 中华肾病研究电子杂志, 2016, 05(02): 56-60.

Hong Xu, Xin Zhang, Hong Chen. Progress of precise diagnosis and treatment for vesicoureteral reflux[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2016, 05(02): 56-60.

膀胱输尿管反流( VUR)是儿童最为常见的泌尿系统疾病,该病使患儿更易出现肾盂肾炎,是儿童尿路感染后肾脏疤痕形成的最重要的风险因素。到目前为止,对VUR的诊断及治疗仍有很多争议,其争议内容主要是围绕着哪些儿童应该评估反流的有无,以及一旦确诊VUR时哪些儿童又应该接受治疗及接受何种治疗。VUR是一种遗传性疾病,但是该病具有种族差异性、遗传异质性等特点,迄今为止国际上尚没有公认的、一致的主要致病基因。明确不同基因突变所致的VUR的研究,有助于做出肾疤痕形成是先天性还是后天性的判断,从而在临床做出精确诊断及精准治疗。

Vesicoureteral reflux (VUR) is the commonest urinary tract diseases in children. It predisposes subjects to acute pyelonephritis, and is the most important risk factor for renal scars formation after urinary tract infections in children. Up to now, controversies still exist on the diagnosis and treatment of VUR, mainly focusing on which children should be assessed for existence of VUR, and which children should receive what kind of treatment once VUR is recognized. In research on its pathogenic mechanisms, VUR has been found to be a genetic disorder with features of racial differences, and genetic heterogeneity, etc. So far, there have not been internationally-recognized consistent major disease-causing genes. Studies to clarify the different gene mutations for causing VUR, will help to judge whether the renal scars are congenital or acquired ones, so as to make precise diagnosis and precise treatment.

[1]
Spencer JD,Schwaderer A,McHugh K, et al. The demographicsand costs of inpatient vesicoureteral reflux management in the USA[J]. Pediatr Nephrol, 2011, 26(11): 1995-2001.
[2]
Printza N,Farmaki E,Piretzi K, et al. Acute phase 99mTc-dimercaptosuccinic acid in infants with first episode of febrile urinary tract infection[J]. World J Pediatr, 2012, 8(1): 52-56.
[3]
Zhang Xin,Hong Xu,Lijun Zhou, et al. Accuracy of early DMSA scan for VUR in young children with febrile UTI[J]. Pediatrics, 2014, 133(1): e30-e38.
[4]
Fouzas S,Krikelli E,Vassilakos P, et al. DMSA scan for revealing vesicoureteral reflux in young children with urinary tract infection[J]. Pediatrics, 2010, 126(3): e513-e519.
[5]
Signorelli M,Cerri V,Taddei F, et al. Prenatal diagnosis and management of mild fetal pycelectasis : implications for neonatal outcome and follow-up[J]. Eur J Obstet Gynecol Reprod Biol, 2005, 118(2): 154-159.
[6]
Roberts KB,Downs SM,Finnell SM, et al. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months[J]. Pediatrics, 2011, 128(3): 595-610.
[7]
National Collaborating Centre for Women′ and Children′s Health (UK). Urinary tract infection in children: diagnosis, treatment and long-term management [M]. London: RCOG Press, 2007.

URL    
[8]
Montini G,Zucchetta P,Tomasi L, et al. Value of imaging studies after a first febrile urinary tract infection in young children: data from Italian renal infection study 1[J]. Pediatrics, 2009, 123(2): e239-e246.
[9]
Peters CA,Skoog SJ,Arant Jr BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children[J]. J Urol, 2010, 184(3): 1134-1144.
[10]
Nguyen HT,Herndon CD,Cooper C, et al. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis[J]. J Pediatr Urol, 2010, 6(3): 212-231.
[11]
Brandstrom P,Jodal U,Sillen U, et al. The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux[J]. J Pediatr Urol, 2011, 7(6): 594-600.
[12]
Hoberman A,Greenfield SP,Mattoo TK, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux[J]. N Engl J Med, 2014, 370(25): 2367-2376.
[13]
Peters CA,Skoog SJ,Arant BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children[J]. J Urol, 2010, 184(3): 1134-1144.
[14]
Routh JC,Bogaert GA,Kaefer M, et al. Vesicoureteral reflux: current trends in diagnosis, screening, and treatment[J]. Eur Urol, 2012, 61(4): 773-782.
[15]
Pennesi M,Travan L,Peratoner L, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial[J]. Pediatrics, 2008, 121(6): e1489-e1494.
[16]
Riedmiller H,Gerharz EW. Antireflux surgery: Lich-gregoir extravesical ureteric tunnelling[J]. BJU Int, 2008, 101(11): 1467-1482.
[17]
Elder JS,Peters CA,Arant BS, et al. Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children[J]. J Urol, 1997, 157(5): 1846-1851.
[18]
Jodal U,Smellie JM,Lax H, et al. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the international reflux study in children[J]. Pediatr Nephrol, 2006, 21(6): 785-792.
[19]
Emir H,Mammadov E,Elicevik M, et al. Transvesicoscopic cross-trigonal ureteroneocystostomy in children: A single-center experience[J]. J Pediatr Urol, 2012, 8(1): 83-86.
[20]
Chung MS,Han SW,Jung HJ, et al. Transvesicoscopic ureteral reimplantation in children with bilateral vesicoureteral reflux: surgical technique and results[J]. J Laparoendosc Adv Surg Tech A, 2012, 22(3): 295-300.
[21]
Casale P,Patel RP,Kolon TF. Nerve sparing robotic extravesical ureteral reimplantation[J]. J Urol, 2008, 179(5): 1987-1989.
[22]
Stanasel I,Atala A,Hemal A. Robotic assisted ureteral reimplantation: current status[J]. Curr Urol Rep, 2013, 14(1): 32-36.
[23]
Hayn MH,Smaldone MC,Ost MC, et al. Minimally invasive treatment of vesicoureteral reflux[J]. Urol Clin North Am, 2008, 35(3): 477-488.
[24]
Kirsch AJ,Perez-Brayfield M,Smith EA, et al. The modified sting procedure to correct vesicoureteral reflux: Improved results with submucosal implantation within the intramural ureter[J]. J Urol, 2004, 171(6 Pt 1): 2413-2416.
[25]
Routh JC,Inman BA,Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: Systematic review[J]. Pediatrics, 2010, 125(5): 1010-1019.
[26]
Lavelle MT,Conlin MJ,Skoog SJ. Subureteral injection of deflux for correction of reflux: analysis of factors predicting success[J]. Urology, 2005, 65(3): 564-567.
[27]
Routh JC,Reinberg Y. Predicting success in the endoscopic management of pediatric vesicoureteral reflux[J]. Urology, 2010, 76(1): 195-198.
[28]
Elder JS,Diaz M,Caldamone AA, et al. Endoscopic therapy for vesicoureteral reflux: A meta-analysis. I. Reflux resolution and urinary tract infection[J]. J Urol, 2006, 175(2): 716-722.
[29]
Vandersteen DR,Routh JC,Kirsch AJ, et al. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer[J]. J Urol, 2006, 176(4 Pt 1): 1593-1595.
[30]
Kirsch A,Hensle T,Scherz H, et al. Injection therapy: Advancing the treatment of vesicoureteral reflux[J]. J Pediatr Urol, 2006, 2(6): 539-544.
[31]
Kirsch AJ,Arlen AM,Leong T, et al. Vesicoureteral reflux index (VURx): a novel tool to predict primary reflux improvement and resolution in children less than 2 years of age[J]. J Pediatr Urol, 2014, 10(6): 1249-1254.
[32]
Kaefer M,Curran M,Treres ST, et al. Sibling vesicoureteral reflux in multiple gestation births[J]. Pediatrics, 2000, 105(4 pt 1): 800-804.
[33]
饶佳,徐虹,阮双岁, 等. 小儿原发性膀胱输尿管返流的临床研究[J]. 中国实用儿科杂志, 2004, 19(8): 465-467.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 周容, 张亚萍, 廖宇, 程晓萍, 管玉龙, 潘广玉, 闫杰, 王贤芝, 苟中山, 潘登科, 李巅远. 超声在基因编辑猪-猴异种并联式心脏移植术中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 617-623.
[3] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[4] 王聪, 李云涛, 唐甜甜, 王鑫蕊, 吕鑫, 范志刚. 多基因检测对激素受体阳性、HER-2阴性乳腺癌新辅助化疗疗效预测的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 292-296.
[5] 费一鸣, 刘卓, 张丽娟. 组学分析在早产分子机制中的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 504-510.
[6] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[7] 奚卫, 王闻卿, 刘玥, 王亚楠, 许学斌. 胃肠炎继发脓毒症感染创伤弧菌ST14514的病原学诊断与文献病例回顾分析[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 293-302.
[8] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[9] 刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[10] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[11] 丁富贵, 吴泽涛, 董卫国. 家族性腺瘤性息肉病临床特征及生物信息学分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 512-518.
[12] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[13] 李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?